HSANZ Free Communications 9: Supportive Care / Infectious Disease / Non Malignant
Tracks
HSANZ
Tuesday, November 7, 2023 |
10:30 AM - 12:00 PM |
Meeting room 217 |
Speaker
Prof Jeff Szer
Haematologist
Peter MacCallum Cancer Centre
Intensive Pegcetacoplan Dosing in the Management of Acute Haemolysis as Part of the 307 Open-Label Extension Study
10:30 AM - 10:45 AMBiography
Professor Szer has expertise in classical and malignant haematology and haemopoietic stem cell transplantation. He is a board member of the International PNH Interest Group and chairs the IPIG PNH Registry Committee. He is a past president of two international BMT societies and is on the editorial board of several international journals.
Dr Danny Hsu
Consultant Haematologist
Haematology Department, Liverpool Hospital
Characteristics of paediatric and adult patients with atypical haemolytic uraemic syndrome (aHUS) treated with eculizumab – an Australian clinical audit.
10:45 AM - 11:00 AMBiography
Dr Danny Hsu is a clinical and laboratory haematologist at Liverpool Hospital. He is the Clinical Lead of Immune Haematology and Director of Therapeutic Apheresis with an interest in thrombotic microangiopathies and complementopathies.
Ricardo Ataide
Tmprss6 siRNA treatment in mice stops hepcidin reduction across pregnancy
11:00 AM - 11:15 AMBiography
Dr Malaika Perchard
Paediatric Haematologist
Royal Children’s Hospital
Genotype to phenotype: what are those dots?
11:15 AM - 11:30 AMBiography
Malaika Perchard is a Paediatric Haematologist with an interest in clinical and laboratory practice. She enjoys looking after children with a broad range of non- malignant haematological conditions including thrombosis, bleeding disorders, cytopenias (low blood counts), iron deficiency anaemia and haemolytic anaemia's.
Prof David Ma
Medical Specialist
St Vincent's Hospital
A novel telemedicine therapeutic intervention to improve the health of post-transplant patients in their home
11:30 AM - 11:45 AMBiography
David Ma, Haematologist, works in the Department of Haematology and BM Transplantation, St Vincent’s Hospital Sydney Australia, and conjoint professor, Faculty of Medicine, UNSW Sydney. He has successfully taken research discoveries to the bedside and over 175 peer-reviewed scientific publications ((total citations 7429 and H-index of 39).
Dr Briony Shaw
Monash Health
Outcomes of patients with haematological malignancy admitted to ICU and factors associated with survival: a retrospective cohort study
11:45 AM - 12:00 PMBiography
Dr Briony Shaw is a clinical and laboratory haematologist (Monash Health) and NHMRC-funded PhD candidate (Monash University) focusing on piloting a home blood transfusion program for haematology patients. She has a particular passion for managing elderly patients and improving supportive care in haematological malignancy.
Chairperson
Stephanie Anderson
Clinical Haematologist
The Alfred Hospital
Annette Neylon
Haematologist
New Zealand Blood Service